BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Cerri S, Mus L, Blandini F. Parkinson's Disease in Women and Men: What's the Difference? J Parkinsons Dis 2019;9:501-15. [PMID: 31282427 DOI: 10.3233/JPD-191683] [Cited by in Crossref: 132] [Cited by in F6Publishing: 141] [Article Influence: 66.0] [Reference Citation Analysis]
Number Citing Articles
1 Chawla P, Rana SB, Kaur H, Singh K, Yuvaraj R, Murugappan M. A decision support system for automated diagnosis of Parkinson’s disease from EEG using FAWT and entropy features. Biomedical Signal Processing and Control 2023;79:104116. [DOI: 10.1016/j.bspc.2022.104116] [Reference Citation Analysis]
2 Fan H, Sheng S, Li D, Li J, Wang G, Zhang F. Heat‐killed Lactobacillus murinus confers neuroprotection against dopamine neuronal loss by targeting NLRP3 inflammasome. Bioengineering & Transla Med 2022. [DOI: 10.1002/btm2.10455] [Reference Citation Analysis]
3 dos Santos Pereira M, Nascimento GCD, Bortolanza M, Michel PP, Raisman-vozari R, Del Bel E. Doxycycline attenuates l-DOPA-induced dyskinesia through an anti-inflammatory effect in a hemiparkinsonian mouse model. Front Pharmacol 2022;13. [DOI: 10.3389/fphar.2022.1045465] [Reference Citation Analysis]
4 Park YH, Suh JH, Kim YW, Kang DR, Shin J, Yang SN, Yoon SY. Machine learning based risk prediction for Parkinson's disease with nationwide health screening data. Sci Rep 2022;12:19499. [DOI: 10.1038/s41598-022-24105-9] [Reference Citation Analysis]
5 Yang Y, Wang Y, Wang C, Xu X, Liu C, Huang X. Identification of hub genes of Parkinson's disease through bioinformatics analysis. Front Neurosci 2022;16. [DOI: 10.3389/fnins.2022.974838] [Reference Citation Analysis]
6 Yang C, Huang J, Wang T, Tan Y, Chen Y, Zhao Z, Qu C, Qu Y. Effects and parameters of community-based exercise on motor symptoms in Parkinson's disease: a meta-analysis.. [DOI: 10.21203/rs.3.rs-2074383/v1] [Reference Citation Analysis]
7 Mandel N, Agarwal N. Role of SUMOylation in Neurodegenerative Diseases. Cells 2022;11:3395. [DOI: 10.3390/cells11213395] [Reference Citation Analysis]
8 Rocca WA, Smith CY, Gazzuola Rocca L, Savica R, Mielke MM. Association of Premenopausal Bilateral Oophorectomy With Parkinsonism and Parkinson Disease. JAMA Netw Open 2022;5:e2238663. [DOI: 10.1001/jamanetworkopen.2022.38663] [Reference Citation Analysis]
9 Lu J, Wang M, Wu P, Yakushev I, Zhang H, Ziegler S, Jiang J, Förster S, Wang J, Schwaiger M, Rominger A, Huang S, Liu F, Zuo C, Shi K. Adjustment for the Age- and Gender-Related Metabolic Changes Improves the Differential Diagnosis of Parkinsonism. Phenomics 2022. [DOI: 10.1007/s43657-022-00079-6] [Reference Citation Analysis]
10 Huang T, Zhao JY, Pan RR, Jiang T, Fu XX, Huang Q, Wang XX, Gong PY, Tian YY, Zhang YD. Dysregulation of Circulatory Levels of lncRNAs in Parkinson's Disease. Mol Neurobiol 2022. [PMID: 36264433 DOI: 10.1007/s12035-022-03086-w] [Reference Citation Analysis]
11 Unda SR, Marciano S, Milner TA, Marongiu R. State-of-the-art review of the clinical research on menopause and hormone replacement therapy association with Parkinson’s disease: What meta-analysis studies cannot tell us. Front Aging Neurosci 2022;14:971007. [DOI: 10.3389/fnagi.2022.971007] [Reference Citation Analysis]
12 Philipe de Souza Ferreira L, André da Silva R, Marques Mesquita da Costa M, Moraes de Paiva Roda V, Vizcaino S, Janisset NRLL, Ramos Vieira R, Marcos Sanches J, Maria Soares Junior J, de Jesus Simões M. Sex differences in Parkinson's Disease: An emerging health question. Clinics (Sao Paulo) 2022;77:100121. [PMID: 36194924 DOI: 10.1016/j.clinsp.2022.100121] [Reference Citation Analysis]
13 Azar J, Jaber Y, Ayyad M, Abu alia W, Owda F, Sharabati H, Zeid H, Khreshi S, Albandak M, Sayyed Ahmad D. Parkinsonism-Hyperpyrexia Syndrome: A Case Series and Literature Review. Cureus 2022. [DOI: 10.7759/cureus.29646] [Reference Citation Analysis]
14 Shen Z, Yu M, Zhang S, Surguchov A. Network Pharmacology and Molecular Docking Analyses Unveil the Mechanisms of Yiguanjian Decoction against Parkinson’s Disease from Inner/Outer Brain Perspective. BioMed Research International 2022;2022:1-25. [DOI: 10.1155/2022/4758189] [Reference Citation Analysis]
15 Kochmanski J, Kuhn NC, Bernstein AI. Parkinson’s disease-associated, sex-specific changes in DNA methylation at PARK7 (DJ-1), SLC17A6 (VGLUT2), PTPRN2 (IA-2β), and NR4A2 (NURR1) in cortical neurons. npj Parkinsons Dis 2022;8:120. [DOI: 10.1038/s41531-022-00355-2] [Reference Citation Analysis]
16 Emin D, Zhang YP, Lobanova E, Miller A, Li X, Xia Z, Dakin H, Sideris DI, Lam JYL, Ranasinghe RT, Kouli A, Zhao Y, De S, Knowles TPJ, Vendruscolo M, Ruggeri FS, Aigbirhio FI, Williams-Gray CH, Klenerman D. Small soluble α-synuclein aggregates are the toxic species in Parkinson's disease. Nat Commun 2022;13:5512. [PMID: 36127374 DOI: 10.1038/s41467-022-33252-6] [Reference Citation Analysis]
17 Sun R, Sugiyama M, Wang S, Kuno M, Sasaki T, Hirose T, Miyata T, Kobayashi T, Tsunekawa T, Onoue T, Yasuda Y, Takagi H, Hagiwara D, Iwama S, Suga H, Arima H. Inflammation in VTA Caused by HFD Induces Activation of Dopaminergic Neurons Accompanied by Binge-like Eating. Nutrients 2022;14:3835. [PMID: 36145208 DOI: 10.3390/nu14183835] [Reference Citation Analysis]
18 Chen F, Chen S, Si A, Luo Y, Hu W, Zhang Y, Ma J. The long-term trend of Parkinson’s disease incidence and mortality in China and a Bayesian projection from 2020 to 2030. Front Aging Neurosci 2022;14:973310. [DOI: 10.3389/fnagi.2022.973310] [Reference Citation Analysis]
19 S. D, Kumaresan A., Prathap Suganthirababu, Surya Vishnuram. Correlation of biomarker cortisol with fatigue and quality of life among men and women with idiopathic Parkinson’s disease. Biomedicine 2022;42:812-816. [DOI: 10.51248/.v42i4.1577] [Reference Citation Analysis]
20 Mikami K, Kamo T, Ichinoseki-sekine N. Sex differences in posture and vertical perception of gait function in patients with Parkinson's disease.. [DOI: 10.21203/rs.3.rs-2009826/v1] [Reference Citation Analysis]
21 Zhao Y, Gagliano Taliun SA. Lipid-lowering drug targets and Parkinson's disease: A sex-specific Mendelian randomization study. Front Neurol 2022;13:940118. [DOI: 10.3389/fneur.2022.940118] [Reference Citation Analysis]
22 Ortega RA, Bressman SB, Raymond D, Ozelius LJ, Katsnelson V, Leaver K, Swan MC, Shanker V, Miravite J, Wang C, Bennett SA, Saunders‐pullman R. Differences in Sex‐Specific Frequency of Glucocerebrosidase Variant Carriers and Familial Parkinsonism. Movement Disorders. [DOI: 10.1002/mds.29197] [Reference Citation Analysis]
23 Saleki K, Banazadeh M, Saghazadeh A, Rezaei N. Aging, testosterone, and neuroplasticity: friend or foe? Rev Neurosci 2022. [PMID: 36017670 DOI: 10.1515/revneuro-2022-0033] [Reference Citation Analysis]
24 Kaya D. Automated gender‐Parkinson's disease detection at the same time via a hybrid deep model using human voice. Concurrency and Computation. [DOI: 10.1002/cpe.7289] [Reference Citation Analysis]
25 Costa HN, Esteves AR, Empadinhas N, Cardoso SM. Parkinson's Disease: A Multisystem Disorder. Neurosci Bull 2022. [PMID: 35994167 DOI: 10.1007/s12264-022-00934-6] [Reference Citation Analysis]
26 Zhang H, Liu X, Liu Y, Liu J, Gong X, Li G, Tang M. Crosstalk between regulatory non-coding RNAs and oxidative stress in Parkinson’s disease. Front Aging Neurosci 2022;14:975248. [DOI: 10.3389/fnagi.2022.975248] [Reference Citation Analysis]
27 Pinizzotto CC, Patwardhan A, Aldarondo D, Kritzer MF. Task-specific effects of biological sex and sex hormones on object recognition memories in a 6-hydroxydopamine-lesion model of Parkinson's disease in adult male and female rats. Hormones and Behavior 2022;144:105206. [DOI: 10.1016/j.yhbeh.2022.105206] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
28 Tryphena KP, Anuradha U, Kumar R, Rajan S, Srivastava S, Singh SB, Khatri DK. Understanding the Involvement of microRNAs in Mitochondrial Dysfunction and Their Role as Potential Biomarkers and Therapeutic Targets in Parkinson’s Disease. JAD 2022. [DOI: 10.3233/jad-220449] [Reference Citation Analysis]
29 Gautam V, Gaurav A, Masand N, Lee VS, Patil VM. Artificial intelligence and machine-learning approaches in structure and ligand-based discovery of drugs affecting central nervous system. Mol Divers 2022. [PMID: 35819579 DOI: 10.1007/s11030-022-10489-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
30 Darweesh SK, De Vries NM, Helmich RC, Verbeek MM, Schwarzschild MA, Bloem BR. Inhibition of Neuroinflammation May Mediate the Disease-Modifying Effects of Exercise: Implications for Parkinson’s Disease. JPD 2022;12:1419-1422. [DOI: 10.3233/jpd-223216] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
31 Aftanas LI, Zhanaeva SY, Al’perina EL, Idova GV, Gevorgyan MM, Dzemidovich SS, Kulikova KI. Effect of Repetitive Transcranial Magnetic Stimulation on Serum Levels of Steroid Adrenal Hormones in Parkinson’s Disease: Sex Differences. Bull Exp Biol Med 2022;173:322-325. [DOI: 10.1007/s10517-022-05542-y] [Reference Citation Analysis]
32 Jeong SH, Lee HS, Lee PH, Sohn YH, Chung SJ. Does dopamine deficiency affect sex-dependent prognosis in Parkinson's disease? Parkinsonism & Related Disorders 2022. [DOI: 10.1016/j.parkreldis.2022.07.012] [Reference Citation Analysis]
33 Chang B, Ni C, Mei J, Xiong C, Chen P, Jiang M, Niu C. Nomogram for Predicting Depression Improvement after Deep Brain Stimulation for Parkinson’s Disease. Brain Sciences 2022;12:841. [DOI: 10.3390/brainsci12070841] [Reference Citation Analysis]
34 Bohlken J, Riedel-Heller S, Kramer A, Kostev K, Schrag A. [Trends in Prevalence of Parkinson's Disease in German General and Neurological Practices from 2010 to 2019]. Fortschr Neurol Psychiatr 2022. [PMID: 35724681 DOI: 10.1055/a-1838-4963] [Reference Citation Analysis]
35 Aljabali AAA, Pal K, Bashatwah RM, Tambuwala MM. Conclusion, Outlook, and Prospects: Bionanomaterials in Clinical Utilization. Bionanotechnology: Next-Generation Therapeutic Tools 2022. [DOI: 10.2174/9789815051278122010010] [Reference Citation Analysis]
36 Chang B, Ni C, Zhang W, Mei J, Xiong C, Chen P, Jiang M, Niu C. Nomogram to Predict Cognitive State Improvement after Deep Brain Stimulation for Parkinson's Disease. Brain Sci 2022;12:759. [PMID: 35741644 DOI: 10.3390/brainsci12060759] [Reference Citation Analysis]
37 Zhu B, Yin D, Zhao H, Zhang L. The immunology of Parkinson's disease. Semin Immunopathol 2022. [PMID: 35674826 DOI: 10.1007/s00281-022-00947-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
38 Koponen M, Bell JS, Lalic S, Watson R, Koivisto AM, Ilomäki J. Treatment initiation for parkinson’s disease in Australia 2013–2018: a nation-wide study. BMC Geriatr 2022;22. [DOI: 10.1186/s12877-022-03095-3] [Reference Citation Analysis]
39 Amin R, Quispe C, Docea AO, Alibek Y, Kulbayeva M, Durna Daştan S, Calina D, Sharifi-Rad J. The role of Tumour Necrosis Factor in neuroinflammation associated with Parkinson's disease and targeted therapies. Neurochem Int 2022;:105376. [PMID: 35667491 DOI: 10.1016/j.neuint.2022.105376] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
40 Boccalini C, Carli G, Pilotto A, Padovani A, Perani D. Gender differences in dopaminergic system dysfunction in de novo Parkinson's disease clinical subtypes. Neurobiology of Disease 2022;167:105668. [DOI: 10.1016/j.nbd.2022.105668] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
41 Baran AH. ANTİPARKİNSON İLAÇLARINA VERİLEN BİREYSEL YANITTA FARMAKOGENETİĞİN ROLÜ. Ankara Universitesi Eczacilik Fakultesi Dergisi 2022. [DOI: 10.33483/jfpau.994367] [Reference Citation Analysis]
42 Fernández-espejo E, Rodríguez de Fonseca F, Gavito AL, Córdoba-fernández A, Chacón J, Martín de Pablos Á. Myeloperoxidase and Advanced Oxidation Protein Products in the Cerebrospinal Fluid in Women and Men with Parkinson’s Disease. Antioxidants 2022;11:1088. [DOI: 10.3390/antiox11061088] [Reference Citation Analysis]
43 Zhu S, Bäckström D, Forsgren L, Trupp M. Alterations in Self-Aggregating Neuropeptides in Cerebrospinal Fluid of Patients with Parkinsonian Disorders. JPD 2022;12:1169-1189. [DOI: 10.3233/jpd-213031] [Reference Citation Analysis]
44 Behl T, Madaan P, Sehgal A, Singh S, Makeen HA, Albratty M, Alhazmi HA, Meraya AM, Bungau S. Demystifying the Neuroprotective Role of Neuropeptides in Parkinson's Disease: A Newfangled and Eloquent Therapeutic Perspective. Int J Mol Sci 2022;23:4565. [PMID: 35562956 DOI: 10.3390/ijms23094565] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
45 Miller SJ, Campbell CE, Jimenez-corea HA, Wu G, Logan R. Neuroglial Senescence, α-Synucleinopathy, and the Therapeutic Potential of Senolytics in Parkinson’s Disease. Front Neurosci 2022;16:824191. [DOI: 10.3389/fnins.2022.824191] [Reference Citation Analysis]
46 Mahale RR, Krishnan S, Divya KP, Jisha VT, Kishore A. Gender differences in progressive supranuclear palsy. Acta Neurol Belg 2022;122:357-62. [PMID: 33595832 DOI: 10.1007/s13760-021-01599-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
47 Khosrow-Khavar F, Azoulay L, Montastruc JL, Montastruc F, Renoux C. Aromatase inhibitors and the incidence of Parkinson disease: A population-based cohort study. Cancer 2022. [PMID: 35363379 DOI: 10.1002/cncr.34208] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
48 Yadav D, Kumar P. Restoration and targeting of aberrant neurotransmitters in Parkinson's disease therapeutics. Neurochem Int 2022;156:105327. [PMID: 35331828 DOI: 10.1016/j.neuint.2022.105327] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
49 Tokatli MR, Sisti LG, Marziali E, Nachira L, Rossi MF, Amantea C, Moscato U, Malorni W. Hormones and Sex-Specific Medicine in Human Physiopathology. Biomolecules 2022;12:413. [DOI: 10.3390/biom12030413] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
50 Choi Y, Kim N, Kim KW, Jo HH, Park J, Yoon H, Shin CM, Park YS, Lee DH, Oh HJ, Lee HS, Park YS, Ahn SH, Suh YS, Park DJ, Kim HH, Kim JW, Kim JW, Lee KW, Chang W, Park JH, Lee YJ, Lee KH, Kim YH. Sex-based differences in histology, staging, and prognosis among 2983 gastric cancer surgery patients. World J Gastroenterol 2022; 28(9): 933-947 [DOI: 10.3748/wjg.v28.i9.933] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
51 Kopishinskaya SV, Velichko IA, Korotysh MA. Pathological postural postures in neurodegenerative diseases. Medicinskij alfavit 2022. [DOI: 10.33667/2078-5631-2022-1-64-70] [Reference Citation Analysis]
52 Korf JM, Ganesh BP, Mccullough LD. Gut dysbiosis and age-related neurological diseases in females. Neurobiology of Disease 2022;168:105695. [DOI: 10.1016/j.nbd.2022.105695] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
53 Caplliure-Llopis J, Escrivá D, Navarro-Illana E, Benlloch M, de la Rubia Ortí JE, Barrios C. Bone Quality in Patients with Parkinson's Disease Determined by Quantitative Ultrasound (QUS) of the Calcaneus: Influence of Sex Differences. Int J Environ Res Public Health 2022;19:2804. [PMID: 35270499 DOI: 10.3390/ijerph19052804] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
54 Zhou L, Wong K, Poon CC, Yu W, Xiao H, Chan C, Mok DK, Wong M. Water Extract of Rhizoma Drynaria Selectively Exerts Estrogenic Activities in Ovariectomized Rats and Estrogen Receptor-Positive Cells. Front Endocrinol 2022;13:817146. [DOI: 10.3389/fendo.2022.817146] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
55 Vitku J, Hill M, Kolatorova L, Kubala Havrdova E, Kancheva R. Steroid Sulfation in Neurodegenerative Diseases. Front Mol Biosci 2022;9:839887. [DOI: 10.3389/fmolb.2022.839887] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
56 Hassin-Baer S, Cohen OS, Israeli-Korn S, Yahalom G, Benizri S, Sand D, Issachar G, Geva AB, Shani-Hershkovich R, Peremen Z. Identification of an early-stage Parkinson's disease neuromarker using event-related potentials, brain network analytics and machine-learning. PLoS One 2022;17:e0261947. [PMID: 34995285 DOI: 10.1371/journal.pone.0261947] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
57 Sepúlveda D, Cisternas-olmedo M, Arcos J, Nassif M, Vidal RL. Contribution of Autophagy-Lysosomal Pathway in the Exosomal Secretion of Alpha-Synuclein and Its Impact in the Progression of Parkinson’s Disease. Front Mol Neurosci 2022;15:805087. [DOI: 10.3389/fnmol.2022.805087] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
58 Pinizzotto CC, Patwardhan A, Aldarondo D, Kritzer MF. Task-specific effects of biological sex and sex hormones on object recognition memories in a 6-hydroxydopamine-lesion model of Parkinson’s disease in adult male and female rats.. [DOI: 10.1101/2022.02.15.480556] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
59 Xing Y, Sapuan AH, Martín-Bastida A, Naidu S, Tench C, Evans J, Sare G, Schwarz ST, Al-Bachari S, Parkes LM, Kanavou S, Raw J, Silverdale M, Bajaj N, Pavese N, Burn D, Piccini P, Grosset DG, Auer DP. Neuromelanin-MRI to Quantify and Track Nigral Depigmentation in Parkinson's Disease: A Multicenter Longitudinal Study Using Template-Based Standardized Analysis. Mov Disord 2022. [PMID: 35165920 DOI: 10.1002/mds.28934] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
60 Meoni G, Tenori L, Schade S, Licari C, Pirazzini C, Bacalini MG, Garagnani P, Turano P, Trenkwalder C, Franceschi C, Mollenhauer B, Luchinat C; PROPAG-AGEING Consortium. Metabolite and lipoprotein profiles reveal sex-related oxidative stress imbalance in de novo drug-naive Parkinson's disease patients. NPJ Parkinsons Dis 2022;8:14. [PMID: 35136088 DOI: 10.1038/s41531-021-00274-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
61 Wang J, Wang C, Wei Y, Zhao Y, Wang C, Lu C, Feng J, Li S, Cong B. Circular RNA as a Potential Biomarker for Forensic Age Prediction. Front Genet 2022;13:825443. [DOI: 10.3389/fgene.2022.825443] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
62 Hadisurya M, Li L, Kuwaranancharoen K, Wu X, Lee Z, Alcalay RN, Padmanabhan S, Tao WA, Iliuk A. Quantitative proteomics and phosphoproteomics of urinary extracellular vesicles define diagnostic biosignatures for Parkinson’s Disease.. [DOI: 10.1101/2022.01.18.22269096] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
63 Bartl M, Dakna M, Schade S, Wicke T, Lang E, Ebentheuer J, Weber S, Trenkwalder C, Mollenhauer B. Longitudinal Change and Progression Indicators Using the Movement Disorder Society-Unified Parkinson’s Disease Rating Scale in Two Independent Cohorts with Early Parkinson’s Disease. JPD 2022;12:437-452. [DOI: 10.3233/jpd-212860] [Reference Citation Analysis]
64 Kang KW, Choi SM, Kim BC. Gender differences in motor and non-motor symptoms in early Parkinson disease. Medicine (Baltimore) 2022;101:e28643. [PMID: 35060552 DOI: 10.1097/MD.0000000000028643] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
65 Subramanian I, Mathur S, Oosterbaan A, Flanagan R, Keener AM, Moro E. Unmet Needs of Women Living with Parkinson's Disease: Gaps and Controversies. Movement Disorders. [DOI: 10.1002/mds.28921] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
66 Cui J, Yuan Y, Wang J, Song N, Xie J. Desferrioxamine Ameliorates Lipopolysaccharide-Induced Lipocalin-2 Upregulation via Autophagy Activation in Primary Astrocytes. Mol Neurobiol 2022. [PMID: 35040039 DOI: 10.1007/s12035-021-02687-1] [Reference Citation Analysis]
67 AlShimemeri S, Di Luca DG, Fox SH. MPTP Parkinsonism and Implications for Understanding Parkinson's Disease. Mov Disord Clin Pract 2022;9:42-7. [PMID: 35005064 DOI: 10.1002/mdc3.13344] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
68 Bhome R, Zarkali A, Thomas GEC, Iglesias JE, Cole JH, Weil RS. Thalamic white matter macrostructure and subnuclei volumes in Parkinson's disease depression. NPJ Parkinsons Dis 2022;8:2. [PMID: 35013327 DOI: 10.1038/s41531-021-00270-y] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
69 Oltra J, Uribe C, Campabadal A, Inguanzo A, Monté-rubio GC, Martí MJ, Compta Y, Valldeoriola F, Junque C, Segura B. Sex Differences in Brain and Cognition in de novo Parkinson's Disease. Front Aging Neurosci 2022;13:791532. [DOI: 10.3389/fnagi.2021.791532] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
70 Mafra M, Lenzi OMW, Silveira FS, Schmitt MV, Oliveira JFD, Sousa CAD. Multimodal exercise program contributes to balance and motor functions in men and women with Parkinson's disease differently: an intervention study. Motriz: rev educ fis 2022;28. [DOI: 10.1590/s1980-657420220015221] [Reference Citation Analysis]
71 程 玉. Research Advances in Effects of Hormonal Changes during the Menstrual Cycle on Neu-rological Diseases. ACM 2022;12:10312-10317. [DOI: 10.12677/acm.2022.12111487] [Reference Citation Analysis]
72 Pellecchia MT, Picillo M, Russillo MC, De Pandis MF, Bonizzoni E, Marjanovic I, Cattaneo C. Efficacy of Safinamide and Gender Differences During Routine Clinical Practice. Front Neurol 2021;12:756304. [PMID: 34970207 DOI: 10.3389/fneur.2021.756304] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
73 何 娟. Research Progress on the Regulation of the Central Nervous System by Dopaminergic Neurons in the Midbrain. ACM 2022;12:10742-10747. [DOI: 10.12677/acm.2022.121115747] [Reference Citation Analysis]
74 Dubreuil-vall L, Laabs TL, Eyre HA, Smith E, Catuara-solarz S. Sex differences in invasive and noninvasive neurotechnologies. Sex and Gender Bias in Technology and Artificial Intelligence 2022. [DOI: 10.1016/b978-0-12-821392-6.00008-x] [Reference Citation Analysis]
75 Scorza FA, Girão MJBC, de Almeida AG, Fiorini AC, Scorza CA, Finsterer J. Women with sleep disorders face increased odds of sudden death in Parkinson's disease. Acta Neurol Belg 2021;121:1881-2. [PMID: 33103206 DOI: 10.1007/s13760-020-01523-y] [Reference Citation Analysis]
76 Searl J, Dietsch AM. Daily Phonatory Activity of Individuals With Parkinson's Disease. J Voice 2021:S0892-1997(21)00346-5. [PMID: 34819239 DOI: 10.1016/j.jvoice.2021.10.004] [Reference Citation Analysis]
77 Sumien N, Cunningham JT, Davis DL, Engelland R, Fadeyibi O, Farmer GE, Mabry S, Mensah-Kane P, Trinh OTP, Vann PH, Wilson EN, Cunningham RL. Neurodegenerative Disease: Roles for Sex, Hormones, and Oxidative Stress. Endocrinology 2021;162:bqab185. [PMID: 34467976 DOI: 10.1210/endocr/bqab185] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 8.0] [Reference Citation Analysis]
78 Wang C, Yang T, Liang M, Xie J, Song N. Astrocyte dysfunction in Parkinson's disease: from the perspectives of transmitted α-synuclein and genetic modulation. Transl Neurodegener 2021;10:39. [PMID: 34657636 DOI: 10.1186/s40035-021-00265-y] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
79 Wang XT, Yu H, Liu FT, Zhang C, Ma YH, Wang J, Dong Q, Tan L, Wang H, Yu JT. Associations of sleep disorders with cerebrospinal fluid α-synuclein in prodromal and early Parkinson's disease. J Neurol 2021. [PMID: 34605986 DOI: 10.1007/s00415-021-10812-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
80 El Kholy S, Wang K, El-Seedi HR, Al Naggar Y. Dopamine Modulates Drosophila Gut Physiology, Providing New Insights for Future Gastrointestinal Pharmacotherapy. Biology (Basel) 2021;10:983. [PMID: 34681083 DOI: 10.3390/biology10100983] [Reference Citation Analysis]
81 Behl T, Madaan P, Sehgal A, Singh S, Sharma N, Bhatia S, Al-Harrasi A, Chigurupati S, Alrashdi I, Bungau SG. Elucidating the Neuroprotective Role of PPARs in Parkinson's Disease: A Neoteric and Prospective Target. Int J Mol Sci 2021;22:10161. [PMID: 34576325 DOI: 10.3390/ijms221810161] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
82 Bhatia TN, Clark RN, Needham PG, Miner KM, Jamenis AS, Eckhoff EA, Abraham N, Hu X, Wipf P, Luk KC, Brodsky JL, Leak RK. Heat Shock Protein 70 as a Sex-Skewed Regulator of α-Synucleinopathy. Neurotherapeutics 2021. [PMID: 34528172 DOI: 10.1007/s13311-021-01114-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
83 Rusz J, Tykalová T, Novotný M, Zogala D, Růžička E, Dušek P. Automated speech analysis in early untreated Parkinson's disease: Relation to gender and dopaminergic transporter imaging. Eur J Neurol 2022;29:81-90. [PMID: 34498329 DOI: 10.1111/ene.15099] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 9.0] [Reference Citation Analysis]
84 Kochmanski J, Kuhn NC, Bernstein AI. Parkinson’s Disease-Associated, Sex-specific Changes in DNA Methylation at PARK7 (DJ-1), ATXN1, SLC17A6, NR4A2, and PTPRN2 in Cortical Neurons.. [DOI: 10.1101/2021.09.08.459434] [Reference Citation Analysis]
85 Nhu NT, Cheng YJ, Lee SD. Effects of Treadmill Exercise on Neural Mitochondrial Functions in Parkinson's Disease: A Systematic Review of Animal Studies. Biomedicines 2021;9:1011. [PMID: 34440215 DOI: 10.3390/biomedicines9081011] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
86 Oltra J, Segura B, Uribe C, Monté-Rubio GC, Campabadal A, Inguanzo A, Pardo J, Marti MJ, Compta Y, Valldeoriola F, Iranzo A, Junque C. Sex differences in brain atrophy and cognitive impairment in Parkinson's disease patients with and without probable rapid eye movement sleep behavior disorder. J Neurol 2021. [PMID: 34345972 DOI: 10.1007/s00415-021-10728-x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
87 Rajib D. Role of neuron specific enolase as a biomarker in Parkinson’s disease. J Neurosci Neurol Disord 2021;5:061-068. [DOI: 10.29328/journal.jnnd.1001052] [Reference Citation Analysis]
88 Samidurai M, Palanisamy BN, Bargues-Carot A, Hepker M, Kondru N, Manne S, Zenitsky G, Jin H, Anantharam V, Kanthasamy AG, Kanthasamy A. PKC Delta Activation Promotes Endoplasmic Reticulum Stress (ERS) and NLR Family Pyrin Domain-Containing 3 (NLRP3) Inflammasome Activation Subsequent to Asynuclein-Induced Microglial Activation: Involvement of Thioredoxin-Interacting Protein (TXNIP)/Thioredoxin (Trx) Redoxisome Pathway. Front Aging Neurosci 2021;13:661505. [PMID: 34276337 DOI: 10.3389/fnagi.2021.661505] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 8.0] [Reference Citation Analysis]
89 He G, Liu CF, Ye Q, Liu Z, Jin M, Shang H, Chen L, Tuo H, Jiang H, Cai J, Joshi K, Cooper J, Zi L, Chen S. Prevalence and profile of nocturnal disturbances in Chinese patients with advanced-stage Parkinson's disease: a cross-sectional epidemiology study. BMC Neurol 2021;21:194. [PMID: 33980158 DOI: 10.1186/s12883-021-02217-5] [Reference Citation Analysis]
90 Bashir SI, Kavitha A. Effect of gender in the onset and progression of Parkinson's disease. 2021 10th International IEEE/EMBS Conference on Neural Engineering (NER) 2021. [DOI: 10.1109/ner49283.2021.9441293] [Reference Citation Analysis]
91 Chen X, Feng W, Ou R, Liu J, Yang J, Fu J, Cao B, Chen Y, Wei Q, Shang H. Evidence for Peripheral Immune Activation in Parkinson's Disease. Front Aging Neurosci 2021;13:617370. [PMID: 33994989 DOI: 10.3389/fnagi.2021.617370] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
92 Wang V, Kuo TT, Huang EY, Ma KH, Chou YC, Fu ZY, Lai LW, Jung J, Choi HI, Choi DS, Li Y, Olson L, Greig NH, Hoffer BJ, Chen YH. Sustained Release GLP-1 Agonist PT320 Delays Disease Progression in a Mouse Model of Parkinson's Disease. ACS Pharmacol Transl Sci 2021;4:858-69. [PMID: 33860208 DOI: 10.1021/acsptsci.1c00013] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
93 Wang H. MicroRNAs, Parkinson's Disease, and Diabetes Mellitus. Int J Mol Sci 2021;22:2953. [PMID: 33799467 DOI: 10.3390/ijms22062953] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
94 Bacelis J, Compagno M, George S, Pospisilik JA, Brundin P, Naluai ÅT, Brundin L. Decreased Risk of Parkinson's Disease After Rheumatoid Arthritis Diagnosis: A Nested Case-Control Study with Matched Cases and Controls. J Parkinsons Dis 2021;11:821-32. [PMID: 33682730 DOI: 10.3233/JPD-202418] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 8.0] [Reference Citation Analysis]
95 Merhi R, Kalyn M, Zhu-Pawlowsky A, Ekker M. Loss of parla Function Results in Inactivity, Olfactory Impairment, and Dopamine Neuron Loss in Zebrafish. Biomedicines 2021;9:205. [PMID: 33670667 DOI: 10.3390/biomedicines9020205] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
96 Zaman V, Shields DC, Shams R, Drasites KP, Matzelle D, Haque A, Banik NL. Cellular and molecular pathophysiology in the progression of Parkinson's disease. Metab Brain Dis 2021;36:815-27. [PMID: 33599945 DOI: 10.1007/s11011-021-00689-5] [Cited by in Crossref: 13] [Cited by in F6Publishing: 17] [Article Influence: 13.0] [Reference Citation Analysis]
97 Qian Y, Zhang Y, He X, Xu S, Yang X, Mo C, Lu X, Qiu M, Xiao Q. Findings in Chinese Patients With Parkinson's Disease: A Content Analysis From the SML Study. Front Psychiatry 2021;12:615743. [PMID: 33603686 DOI: 10.3389/fpsyt.2021.615743] [Reference Citation Analysis]
98 Singh NN, Hoffman S, Reddi PP, Singh RN. Spinal muscular atrophy: Broad disease spectrum and sex-specific phenotypes. Biochim Biophys Acta Mol Basis Dis 2021;1867:166063. [PMID: 33412266 DOI: 10.1016/j.bbadis.2020.166063] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 10.0] [Reference Citation Analysis]
99 Bakeberg MC, Gorecki AM, Kenna JE, Jefferson A, Byrnes M, Ghosh S, Horne MK, McGregor S, Stell R, Walters S, Chivers P, Winter SJ, Mastaglia FL, Anderton RS. Differential effects of sex on longitudinal patterns of cognitive decline in Parkinson's disease. J Neurol 2021;268:1903-12. [PMID: 33399968 DOI: 10.1007/s00415-020-10367-8] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 11.0] [Reference Citation Analysis]
100 Rastogi S, Sharma V, Bharti PS, Rani K, Modi GP, Nikolajeff F, Kumar S. The Evolving Landscape of Exosomes in Neurodegenerative Diseases: Exosomes Characteristics and a Promising Role in Early Diagnosis. Int J Mol Sci 2021;22:E440. [PMID: 33406804 DOI: 10.3390/ijms22010440] [Cited by in Crossref: 41] [Cited by in F6Publishing: 46] [Article Influence: 41.0] [Reference Citation Analysis]
101 Crispino P, Gino M, Barbagelata E, Ciarambino T, Politi C, Ambrosino I, Ragusa R, Marranzano M, Biondi A, Vacante M. Gender Differences and Quality of Life in Parkinson's Disease. Int J Environ Res Public Health 2020;18:E198. [PMID: 33383855 DOI: 10.3390/ijerph18010198] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 6.5] [Reference Citation Analysis]
102 Edinoff A, Sathivadivel N, McBride T, Parker A, Okeagu C, Kaye AD, Kaye AM, Kaye JS, Kaye RJ, M Sheth M, Viswanath O, Urits I. Chronic Pain Treatment Strategies in Parkinson's Disease. Neurol Int 2020;12:61-76. [PMID: 33218135 DOI: 10.3390/neurolint12030014] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
103 Liu J, Xu F, Nie Z, Shao L. Gut Microbiota Approach-A New Strategy to Treat Parkinson's Disease. Front Cell Infect Microbiol 2020;10:570658. [PMID: 33194809 DOI: 10.3389/fcimb.2020.570658] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 8.0] [Reference Citation Analysis]
104 Göttgens I, van Halteren AD, de Vries NM, Meinders MJ, Ben-Shlomo Y, Bloem BR, Darweesh SKL, Oertelt-Prigione S. The Impact of Sex and Gender on the Multidisciplinary Management of Care for Persons With Parkinson's Disease. Front Neurol 2020;11:576121. [PMID: 33071952 DOI: 10.3389/fneur.2020.576121] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
105 Conner MR, Jang D, Anderson BJ, Kritzer MF. Biological Sex and Sex Hormone Impacts on Deficits in Episodic-Like Memory in a Rat Model of Early, Pre-motor Stages of Parkinson's Disease. Front Neurol 2020;11:942. [PMID: 33041964 DOI: 10.3389/fneur.2020.00942] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
106 Marras C, Chaudhuri KR, Titova N, Mestre TA. Therapy of Parkinson's Disease Subtypes. Neurotherapeutics 2020;17:1366-77. [PMID: 32749651 DOI: 10.1007/s13311-020-00894-7] [Cited by in Crossref: 22] [Cited by in F6Publishing: 17] [Article Influence: 11.0] [Reference Citation Analysis]
107 Szefler-Derela J, Arkuszewski M, Knapik A, Wasiuk-Zowada D, Gorzkowska A, Krzystanek E. Effectiveness of 6-Week Nordic Walking Training on Functional Performance, Gait Quality, and Quality of Life in Parkinson's Disease. Medicina (Kaunas) 2020;56:E356. [PMID: 32708938 DOI: 10.3390/medicina56070356] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
108 Ferman TJ, Aoki N, Boeve BF, Aakre JA, Kantarci K, Graff-Radford J, Parisi JE, Van Gerpen JA, Graff-Radford NR, Uitti RJ, Pedraza O, Murray ME, Wszolek ZK, Reichard RR, Fields JA, Ross OA, Knopman DS, Petersen RC, Dickson DW. Subtypes of dementia with Lewy bodies are associated with α-synuclein and tau distribution. Neurology 2020;95:e155-65. [PMID: 32561678 DOI: 10.1212/WNL.0000000000009763] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 13.5] [Reference Citation Analysis]
109 Joseph TP, Jagadeesan N, Sai LY, Lin SL, Sahu S, Schachner M. Adhesion Molecule L1 Agonist Mimetics Protect Against the Pesticide Paraquat-Induced Locomotor Deficits and Biochemical Alterations in Zebrafish. Front Neurosci 2020;14:458. [PMID: 32547358 DOI: 10.3389/fnins.2020.00458] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
110 Kawahata I, Fukunaga K. Degradation of Tyrosine Hydroxylase by the Ubiquitin-Proteasome System in the Pathogenesis of Parkinson's Disease and Dopa-Responsive Dystonia. Int J Mol Sci 2020;21:E3779. [PMID: 32471089 DOI: 10.3390/ijms21113779] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 7.5] [Reference Citation Analysis]
111 Tower J, Pomatto LCD, Davies KJA. Sex differences in the response to oxidative and proteolytic stress. Redox Biol 2020;31:101488. [PMID: 32201219 DOI: 10.1016/j.redox.2020.101488] [Cited by in Crossref: 37] [Cited by in F6Publishing: 30] [Article Influence: 18.5] [Reference Citation Analysis]